Emergex to Launch Phase I Trial for New T-Cell Priming COVID-19 Vaccine
A next-generation COVID-19 vaccine, developed by British biotech Emergex, designed to prime T-Cells to rapidly remove viral-infected cells and offer
Read more
T-cell
FDA OK’s Tecartus® CAR T-cell Therapy for B-cell Acute Lymphoblastic Leukemia
Kite Pharma, a Gilead Company, announced on Friday that the U.S. FDA has granted approval for CAR T-cell therapy Tecartus®
Read more
Aleta Biotherapeutics and Cancer Research UK Collaborate to Advance Blood Cancer Therapy
Aleta Biotherapeutics (‘Aleta’) and Cancer Research UK today announced a partnership to advance the early phase clinical development of Aleta’s
Read more
Cell Therapy Facility, Leiden Bio Science Park, Bristol Myers Squibb, Netherlands
Bristol-Myers Squibb is investing in a brand new cell therapy facility which will be located at the Leiden Bio Science
Read more
Shorla Pharma Files FDA Priority Review for T-cell Leukemia Treatment
Irish pharmaceutical company Shorla Pharma Limited (‘Shorla’), has reported that it has successfully filed a priority review application for its
Read more